An observational study in COVID-2019 Pneumonia and Pulmonary Rehabilitation, sponsored by China-Japan Friendship Hospital. Status unknown at 3 sites in China. Open to participants aged 20 Years to 85 Years. Per ClinicalTrials.gov, last updated 2020-07-17.
Sponsored by China-Japan Friendship Hospital · Observational
The noval coronavirus disease 2019 (COVID-19) would cause physical and psychological dysfunctions in infected patients. We expect that an intelligence-based remote pulmonary rehabilitation scheme could improve patients' health status after hospital discharge. The intelligence-based remote pulmonary rehabilitation program is designed in a real-world and prospective manner, aiming to evaluate the efficacy of rehabilitation among 200 patients in the epicenter of China (Wuhan City) according to their varied adherence. An eight-week rehabilitation scheme, including two weeks for physicians and physiotherapists remotely guided training, and six weeks for patient self-management, will be addressed. The primary outcome of current study is six-minute walking distance and lung function, and secondly respiratory muscle strength, physical fitness assessment, symptoms and quality of life, etc. will also be assessed. Recruited patients will be followed up at week 2, 4, 8 after enrollment and at month 1, 3, 6, 12 after the rehabilitation training completed, respectively. The study has been approved by the ethics committee of China-Japan Friendship Hospital and three participating centers in Wuhan City.
2,044 studies on the registry are indexed under Pneumonia; 283 are open to participants now.
This study's planned enrollment of 200 is close to the median of 203 across 688 observational studies indexed under Pneumonia.
Browse Pneumonia studies →China-Japan Friendship Hospital is the lead sponsor of 173 studies on the registry; 109 are open to participants now.
Counted across the registry records on this site, refreshed daily.
All discharged COVID-19 pneumonia patients who have signed the informed consent and met above eligibility criteria will be enrolled in this study.
Exclusion criteria:
One will be considered as withdrawal if consent is revoked, lost to follow-up, or unable to take the pulmonary rehabilitation scheme due to severe exacerbation, comorbidities, injury or trauma, etc.
All enrolled participants will be given 8 weeks (online 2 weeks + offline 6 weeks) pulmonary rehabilitation intervention, and will be followed up for at least one year, to assess their adherence and efficacy of the rehabilitation program.
Behavioral: Remote pulmonary rehabilitation
The pulmonary rehabilitation intervention includes respiratory exercise, barehanded aerobic training, exercise prescription of elastic band impedance training, respiratory muscle strength training, etc.
Six-minute walking distance (6MWD)
Walking distance within six minutes
Time frame: One year
Pulmonary function
Forced expiratory volume in one second (FEV1), forced vital capacity (FVC), etc.
Time frame: One year
Respiratory muscle strength
Maximal inspiratory pressure, maximal expiratory pressure, etc.
Time frame: One year
Physical fitness assessment
Two-minute walking test, short physical performance battery, grip strength of both upper limbs, knee extension strength of both lower limbs, etc.
Time frame: One year
Symptom
Modified British Medical Research Council (mMRC) dyspnea scale, etc.
Time frame: One year
Psychological evaluation
Self-training depression scale (SDS) and self-rating anxiety scale (SAS)
Time frame: One year
Quality of life
36-item short-form health survey (SF-36), etc.
Time frame: One year
Physical activity
International physical activity questionnaire (IPAQ)
Time frame: One year
Proportion of returning to society
Proportions of returning to routine work and normal life
Time frame: One year
Plan to share: No
This study is status unknown, as verified in Jul 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
China-Japan Friendship Hospital